EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 04 February 2021

Video | #WeWontRest until we beat cancer

News

Cancer experts, patients and industry applaud Europe’s Beating Cancer Plan and reemphasise...
03 February 2021

The Plan will guide country efforts and includes commitment to shared goals and actions Read more

EFPIA response to the European Health Union consultations
02 February 2021

Strengthening Europe’s capacity to prepare and respond to public health threats Read more

EFPIA Statement in response to EU Export Restrictions for COVID-19 vaccines
29 January 2021

The establishment by the European Commission of an export authorisation system for Member States to use regarding COVID-19... Read more

Blogs

IMI Impact: Beating cancer – together (Guest blog)
04 February 2021 - Holger Hess-Stumpp

With €190 million invested since 2008, the Innovative Medicines Initiative (IMI) is advancing the fight against cancer... Read more

Improving cancer literacy in Europe to save time, costs and lives (Guest Blog)
02 February 2021 - Kristine Sørensen

Improved cancer literacy of patients and communication skills of health professionals involved in cancer-related services... Read more

Events

Unlocking the Potential of Precision Medicine in Europe
23 February 2021 (Virtual Event)

How to improve cancer care through broader access to quality biomarker testing Read more

DIA Europe 2021
15 March 2021 (Virtual event)

Dedicated to Advancing Healthcare Priorities Read more

We published

Electronic product information: From principles to actions
03 February 2021 (Publications)

AESGP, EFPIA and Medicines for Europe reflections on EMA-HMA–EC Key principles for electronic product information Read more

What we are reading

NEURONET Knowledge Base
On 04 February 2021 (Neuronet)

The NEURONET Knowledge Base brings together key information about the various projects of the Innovative Medicines Initiative... Read more

This is the time to collaborate for a global victory over Covid
On 31 January 2021 (The Guardian)

Richard Torbett and Nathalie Moll: "Vaccine development and production are worldwide efforts; national disputes must... Read more

EU pharma boss urges for unity, avoid vaccine trade war
On 29 January 2021 (Euractiv)

Nathalie Moll: “I think we need to focus on the fact that we all have the same objective in mind, vaccinating as many... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu